This document provides guidance on optimizing oocyte pick-up (OPU) and embryo transfer (ET) procedures in IVF. It discusses key steps in OPU including prior assessments, equipment, the procedure itself, and complications. Factors affecting a successful ET are also reviewed such as embryo selection, catheter choice, ultrasound guidance, and embryo placement. The importance of minimizing trauma and having an experienced clinician is emphasized. Quality assurance measures like ongoing training and monitoring outcomes are recommended.
Patient selection and work-up
Ovarian stimulation
Monitoring of follicular growth and endometrial development
Timing of insemination
Number of inseminations
Semen preparation
Insemination procedure
Luteal support
Since the first formal description of LPD in 1949 as a possible cause of infertility and recurrent miscarriage by Jones. Innumerable investigations have been undertaken in an effort to verify its existence or to characterize its pathophysiology, diagnosis, and treatment. The consensus of the literature is that LPD does exist and that its cause is multifactorial like abnormal folliculogenesis, inadequate LH surge,inadequate secretion of progesterone by the corpus luteum, aberrant end-organ response by the endometrium.
Invited Lecture delivered by Dr Sujoy Dasgupta in the Annual Conference of ISAR (Indian Society of Assisted Reproduction) held at Kolkata in November, 2019
Dr Parul Katiyar discusses simple strategies to optimize clinical outcome of Intra Uterine Insemination (IUI). She talks about the importance of appropriate patient selection and choosing the correct stimulation protocol, among other factors.
Ovarian reserve refers to the reproductive potential left within a woman's two ovaries based on number and quality of eggs. Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of the remaining eggs
Patient selection and work-up
Ovarian stimulation
Monitoring of follicular growth and endometrial development
Timing of insemination
Number of inseminations
Semen preparation
Insemination procedure
Luteal support
Since the first formal description of LPD in 1949 as a possible cause of infertility and recurrent miscarriage by Jones. Innumerable investigations have been undertaken in an effort to verify its existence or to characterize its pathophysiology, diagnosis, and treatment. The consensus of the literature is that LPD does exist and that its cause is multifactorial like abnormal folliculogenesis, inadequate LH surge,inadequate secretion of progesterone by the corpus luteum, aberrant end-organ response by the endometrium.
Invited Lecture delivered by Dr Sujoy Dasgupta in the Annual Conference of ISAR (Indian Society of Assisted Reproduction) held at Kolkata in November, 2019
Dr Parul Katiyar discusses simple strategies to optimize clinical outcome of Intra Uterine Insemination (IUI). She talks about the importance of appropriate patient selection and choosing the correct stimulation protocol, among other factors.
Ovarian reserve refers to the reproductive potential left within a woman's two ovaries based on number and quality of eggs. Diminished ovarian reserve is the loss of normal reproductive potential in the ovaries due to a lower count or quality of the remaining eggs
Dr.Pragnesh Shah is Gynaecological Endoscopic surgeon from Ahmedabad,Gujarat,India and having keen interest in Gynaecological Endoscopic Training. He is having experience of most of the difficult and complicated laparoscopic and hysteroscopic surgeries with world class infra structure in Ahmedabad.
He has given Gynaecological Endoscopic Training to many Gynaecologists and surgeons of the world.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
2. Definition
Oocyte Pick-up (OPU) is an ultrasound-guided technique in which
oocytes are aspirated using a needle connected to a suction pump.
3. Optimising OPU
Several steps:
1. Measues Prior to OPU
2. Equipment and consumables
3.OPU preparation
4. OPU procedure
5. Post-procedure care
6. Associated pathologies and cautions during OPU
7. Complications and risks
8. Future developments
9. Training and competence
10. Quality assurance and performance
4.
5. Prior to OPU
Pelvic Ultrasound –
performed before starting an ART treatment
(i) to decide the ovarian stimulation protocol,
(ii) to determine anatomical abnormality/
malposition of the ovaries/accessibility of ovaries
(iii) to assess ovarian placement and
ovarian/follicular accessibility after previous
surgery (gynaecological surgery for myomas,
endometriomas, adhesions
(iv) detection of recent lesions(endometrial
abnormalities /ovarian cysts)
(Grimbizis et al., 2016)
6. Prior to OPU
• Pre-OPU 3D Ultrasound and Doppler :helpful , familiarize with the anatomy
of the patient, and to prevent (vascular) complications.
• Time frame to perform the US:
discretion of the clinician.,
within 4-6 months from start of ovarian stimulation,
shortened in cases of significant conditions (endometriosis, surgery, specific
symptoms).
T WG recommends a baseline US closer to the OPU to highlight any difficulties or
reconfirm previous findings.
7. Prior to OPU
Vaginal infection screening (by taking a vaginal sample for bacteriological examination) :
In asymptomatic patients :unclear
In symptomatic women: recommended to perform specific testing for cervical and
vaginal infections and take appropriate actions.
Patient medical history - depends on local regulations of pre-operative management.
No evidence with regard to preventing complications.
use of medications important - use of blood thinning agents (aspirin and others)
Relevant previous surgeries, and any relevant disease or deficit of coagulation
factors.
Information provision and informed consent
Verbal and written information, according to local templates, explaining procedure
and risks
8. EQUIPMENT AND CONSUMABLES
• Equipped as per European standards/local regulations
The following equipment for OPU should be available on a
sterile operation table:
• sterile small gauzes
• disposable /reusable speculum for cervical examination
and to visualize any bleeding site
• test tube warmer and heating block should be available
(at 37°C),
• culture medium for flushing should be prepared and ready
at 37°C.
• Additional equipment and consumables : ovary clamps,
sponge holder, vaginal surgery equipment, (absorbable)
sutures.
• Resuscitation equipment: reversal anesthetic drugs, a
prepared kit for anaphylactic shock treatment and oxygen
9. EQUIPMENT AND CONSUMABLES
Ultrasound system and transducer:
• High frequency TVS transducer(5-8MHZ) TAS(2-6 MHZ)
• Regular software calibration
• Serviced as per manufacturers instructions
• Correlate measurements of auto follicular measurements with oocyte
maturity
• Appropriate disinfection Protocol for transducer
• Powder free transducer covers used,latex free covers used if patient allergic
• Avoid lubrication on outside of probe cover: gametotoxic,embryotoxic
10. EQUIPMENT AND CONSUMABLES
NEEDLE:
• Single lumen(17-18 G) used commonly ,
needle with edging preferred
• Double lumen: Used in smaller
follicles/where flushing is needed
• Transclucent tubing to visualize aspirated
fluid
• Needle guide disposable or sterilized
• Check needle patency and aspiration
ability before opu
Suction Pump:
100-200mmHg used
Maintain constant pressure as changes
cause turbulence
11.
12. Basic principles of the OPU technique
Position of patient: patient places her buttocks at the edge of the gynaecological couch and the operator is standing or sitting in
between the patient’s abducted and supported legs.
Transvaginal transducer : technique of holding, Placing the transducer parallel to hand of the operator, L-R orientation ,Top-Down
orientation of transducer
Avoid contaminating the needle tip of the probe when introducing it in the vagina, by keeping the needle inside the needle guide
until ready to pierce the vagina
Position of ovary should be lined up to the most accessible position on the screen. The transducer should be against the ovary
(through the vaginal wall).
Follicular Aspiration: Carefully insert the needle inside the follicle. Needle should be inserted in the middle of the ovary to prevent
the ovary from moving and needle to cause injury to adjacent organs. The echogenic tip of the needle should be identified during all
maneuvers. The needle guide seen on the monitor can facilitate safer insertion as it projects where the needle tip will progress. - It is
advised to keep the needle in the centre of the follicle during aspiration and observe the follicle walls to collapse around the tip. - The
needle tip markers must be observed at all times as it is manoeuvred within the ovaries and into each follicle; the needle tip should
never be advanced if not visible.
Follicular Aspiration Aspirate the follicular fluid containing the oocyte/cumulus complex by application of suction. - The walls of the
follicle collapse as the fluid is aspirated; before moving the needle to the next follicle, the operator should ensure that all the follicular
fluid is withdrawn. - The needle can be advanced into an adjacent follicle or withdrawn to the edge of the ovary; realignment is
needed to advance into another follicle. Minimize as far as possible repetitive puncture through the vaginal wall. - Avoid lateral
movements of the needle to reduce the risk of vascular damage. - Do not move the transducer with the needle in the advanced
position. - Puncture all follicles, especially if there is a high risk of ovarian hyperstimulation syndrome (OHSS). - Flush the needle
between the two ovaries to avoid any potential blockage caused by blood clots.
13. Post-procedure care
• After the procedure, patients should remain in bed at the centre for recovery (about 2 hours, or
less if the procedure was performed with local anesthetics only).
• General status, abdominal distension, blood pressure and heart rate should be monitored by a
nurse.
• In cases of significant pain or abdominal distension, a blood analysis and/or an ultrasound scan,
should be performed before discharge to check for potential intra-abdominal bleeding.
• Patients should be able to eat, drink, and pass urine before discharge.
• Check awareness, orientation, and respiratory rate.
• A written information leaflet about post-care procedures, complications, and a 24 h emergency
number should be provided.
• In patients with hematoma, bleeding or infection after the OPU, antibiotic coverage is
recommended.
• Procedures should be in place for when severe complications occur, including hospital admission
arrangements, specialist responsibility and continued care.
• Provide patients with a leaflet with written information and a 24 h emergency number.
14.
15. Complications
Infection:
• from vaginal puncture leading to contamination from vaginal bacteria into intra-peritoneal space
• presence of latent pelvic infection /pelvic endometriosis /teratoma : contributing factors
Bleeding:
usually unremarkable
• Haemoperitoneum after OPU :defined as a haemoglobin reduction >2g/day, an increase in the pelvic free fluid >200 ml or a calculated blood loss
>500 ml. –
Paralysis:
After para-cervical block, a transient leg paresis may develop, which usually disappears after 2-4 h.
Resuscitation protocol:
The IVF centre should have proactively established policies with respect to how to provide patient resuscitation and access to surgical theatre in case of
internal bleeding or other organ injury in a haemodynamically unstable patient (safety standard).
Safety standard:
OPU video recording help to identify reasons for complications ,improvement of OPU technique with respect to ultrasound settings for clear imaging
and types of manoeuvres during oocyte aspiration.
Registration of complications:All severe complications should be registered according to local requirements. It is recommended that more details on
severe complications are gathered from the EIM data collection.
• (Kelada and Ghani, 2007).
16.
17. Competency Criteria for OPU
• the number of oocytes collected : >7
• the number of ovarian punctures :<3
• the ratio of number of oocytes retrieved to the number of follicles aspirated
(80%)
• Any complications from the procedure, in the short or long term
• the duration of the OPU procedure < 45 mins
• Oocyte recovery rate:% of follicles >15mm diameter yielding COC (85-100%)
• Oocyte maturity rate:%of recovered oocytes at Metaphase 2 (75-90%)
• No.of OPU’s :30 under supervision and 50 independently
• 250 nos : expert!!
Dessolle et al., 2014, Panayotidis, 2017
18. Quality assurance and performance
• Documentation : clear ,readable, OPU description with images and
results (fx. how many oocytes obtained, difficulties during procedure,
information for future audit,about the equipment)
• Key performance indicators analysis : undertaken at least once per
year in the IVF centre.
• Annual audit of OPU :at least once a year. Done by external auditor/
quality managers /members of same team observing each other
19. Recommendations for future research in OPU
Further research is recommended on the following aspects of OPU:
• Value of FBC or any additional test (microbiology) before OPU for
prevention of complications
• Value of antibiotic prophylaxis in low-risk patients
• Value of flushing to increase number of eggs retrieved
• Effect of different aspiration pressures on oocyte yield
• Complications rates related to the OPU performance under sedation
versus general anaesthesia.
20. Future developments
Doppler studies :
• useful to detect vascular areas in case of doubt in 2D ultrasound imaging
• differentiate from hypo-echogenic areas that look alike as superficial follicles
versus iliac or para-ovarian vessels
Artificial intelligence
• based on US features, patient profile and biochemical metrics information, can be
used as a predictor of how much the follicle grows in the next few days.
• predicting the growth of poor responders’ follicles
• Another application could be to classify the follicles during the process of growth
and use this information in OPU and embryo selection for transfer.
21. Associated pathologies /cautions during OPU
• Management of hydrosalpinx : removal or clipping before OPU (Song et al., 2017).
If discovered during OPU: first option should be oocyte or embryo cryopreservation
• Patients with potential infectious risk (HIV, hepatitis) : managed in an isolated circuit / in specialized centres
to avoid cross-contamination.
• In women with endometriosis : Endometriomas should not be aspirated during OPU,
puncture of endometriomas avoided to prevent contamination of follicular aspirate and reduce the risk of
intra-abdominal infection
• Dermoid cysts/Teratoma: should not be punctured during OPU, increases risk of PID and peritonitis. If an
endometrioma or a hemorrhagic follicle is inadvertently punctured, the needle should be immediately
withdrawn and flushed with media, and the collecting tube should be changed.
• Borderline ovarian tumours: unclear whether ART procedures are associated with an increased risk of
recurrence
• PCOS: Increased risk for bleeding has been suggested in lean women
Benaglia et al., 2008, Kasapoglu et al., 2018, Moini et al., 2005, Villette et al., 2016).
23. Factors affecting Embryo Transfer Outcome
Before ET
Embryo selection and Grading
Choice of catheter
Patient relaxation before procedure
Role of Ultrasound and Mock embryo
transfer
Damage to endometrium
Experience of Clinician
During Embryo Transfer
Position of Patient during ET
Technique of ET
Cervical mucous Removal
Ultrasound Guided ET
Type of ET media
Time Interval
Embryo placement in Uterine cavity
Post Embryo Transfer
Bed Rest
Sexual Intercourse
Medications post transfer
24. Embryo grading and selection
• Morphological grading of embryos
• Time lapse techniques
• AI selection
• Embryo metabolomics:
Resp rate,glucose consumption,NO levels,Aminoacid turnover
• Delaying transfer from day2/3 to day 5/6
25. Choice of catheter
Ideal : soft catheter : Co axial variety
avoids any trauma to endocervix / endometrium
malleable ,pliable to negotiate canal
AND smooth tip, nontraumatic
Co axial variety: outer rigid sheath minimally used ,stop short of the internal
os
Rigid catheter : special cases
needed to pass through resistance in internal os.
essential that these rigid catheters are malleable
26. Role of Ultrasound
• Measuring and evaluating cervico- uterine angle,
length and direction, diagnosing any fibroids
encroaching or distorting cervical canal
• To choose the most suitable catheter for the embryo
transfer.
• To discover any unanticipated difficulty in entering the
uterine cavity,
• Assessment of Endometrial thickness(>8mm,Triple line,
Volume> 2.5ml)
USG guided ET : Beneficial!!
27. Damage to endometrium
Endometrial disruption : negative impact
Due to
• Bleeding in uterine cavity
• Inflammation of endometrial lining
• Plugging of ET catheter
• Retention of embryos
• Initiation of Uterine contractions and expulsion of embryos
28. Experience of Clinician
• Clinician's skill and acumen: Non traumatic transfer
• Clinician’s Experience : Influences OUTCOME
29. Embryo Transfer Technique
• Patient Counselling: Details of Fertilisation rate, available embryos and selected embryos
• Pre Procedure Requirement:
• Preprocedure medication
• Fluid intake
• Ultrasound for bladder status
• Procedure:
• Insertion of Cusco's Speculum and visualisation of cervix
• Cleaning of cervical mucous
• Ultrasound visualisation of cervical canal and Uterine cavity
• Insertion of Outer Sheath loading Embryos in Inner Catheter
• Deposition Of Embryos into Uterine cavity
• Inspection for retained Embryos and re transfer
30. Factors During Embryo Transfer
• Position of patient:
Lithotomy preferable, Bladder partially full
• Technique:
Poor embryo transfer technique leads to 30% of all failures
Gentle and atraumatic, painless,
Lack of blood, mucus ,endometrial cells at catheter tip
Cusco’s speculum recommended
Avoid use of Vulsellum to hold cervix
Avoid touching uterine fundus
Gentle manipulation, avoid pushing Cervix
Karande et al., 1999; Hearns-Stokes et al., 2000),
31. Cervical Mucous Removal
Cleaning mucous at cervix before ET with sterile applicator or
aspiration of mucous with syringe
• Prevention of entanglement of embryos
• Prevent expulsion of embryos
• Cervical mucus culture tested positive in 71% of cases : reduced
pregnancy rates stick to the catheter and inadvertently remove the
embryo during catheter withdraw
32. USG Guidance During ET
USG guidance: Preferred cf Touch Technique
• Visualise echogenic tip
• Determine exact site of embryo deposition
• Ensures that embryo column and Air bubble interface not displaced after ET
• Visualize the cervical uterine angle for negotiation of catheter and minimise
trauma
33. Time interval
• Interval between catheter loading and the discharge of the
embryos into the cavity affected IVF outcomes(Temp ,humidity
,PH changes outside Incubator)
• Delay >120 seconds: decrease in pregnancy rates from 31.6%
to 19.1% and a decrease in implantation rate from 15.9% to
9.4%.
• Load catheter only when patient is positioned, cleaned ,draped
and Ultrasound focussed on uterine cavity
• extra care and time should be given to embryo transfer, which is the
most critical step in IVF.
34. Volume and type of transfer media
Media type:
• High Protein content, physiological concentration,
• Use of Hyaluronan /fibrin sealants in transfer media
Air Bubble technique:
Embryos transferred bracketed between 2 air bubble columns
• Bubbles mark position of embryos in catether
• Protects against inappropriate placement,prevents entanglement to
mucous plug
• Madani et al. injected an additional amount of air after the embryo
fluid column was injected. This extra air injection resulted in a
significant improvement in implantation and pregnancy rates.
35. Deposition of Embryos in Uterine cavity
• Ideal site: Mid cavity gives better
implantation
• Maximum Implantation Point (MIP) :
intersection of two imaginary lines
formed by extending the fallopian tube
course inside uterine cavity
36. Proper delivery of the embryos inside the uterine
cavity
• Ensure embryo transfer catheter has passed the internal
os and entered the uterine cavity
( test :rotate the catheter 360°. If it recoils, it means that
it is curved inside the cervical canal)
• Ensure alignment between the catheter and utero–
cervical canal : gently curving the outer sheath of the
catheter will overcome this problem in most cases
• Straightening the utero–cervical angle can be achieved by
a full bladder
• Facilitating entry of catheter by gently maneuvering the
vaginal speculum
37. Withdrawal of Catheter
Wait for the release of embryos vs Immediate withdrawal
No differences in the pregnancy rate between withdrawal of the catheter immediately
after embryo deposit or after a 30 s wait
If the fluid flows in a laminar way forward from the catheter tip toward the fundus, as
visualized by ultrasound, pregnancy rates are improved.
The effect of forward laminar flow resulted in a 55.9% pregnancy rate, compared with
28.6% without forward laminar flow
Martinez et al., 2001,Wisanto et al., 1989; Al-Shawaf et al., 1993).
Rapid withdrawal may create a negative pressure and result in the withdrawal of
the embryos
R.T. Mansour, M.A. Aboulghar.,Human Reproduction, Volume 17, Issue 5, May 2002, Pages 1149–1153
38. Rapid vs Slow Injection
• percentage of embryos shrunken/ collapsed increased in the
rapid injection group.
• rates of apoptosis in the embryos of the rapid injection group
were increased.
• embryo trauma may be related to the rapidity of injection
• rapid injection may lead to embryo placement issues and
possibly promote ectopic pregnancies
care should be taken to inject the fluid as slowly as possible
39. Difficult vs Easy transfer
• Tomás et al. evaluated 4,807 ETs with regard to the degree of difficulty.
Easy or intermediate transfers resulted in a 1.7-fold higher pregnancy rate
than difficult transfers (P<.0001; 95% confidence interval 1.3–2.2)
• Avoiding difficult ET is important to optimize clinical outcomes, and ultrasound
guidance seems to be a key adjunct toward this goal
40. Fresh vs Frozen transfer
• Impaired endometrial receptivity during fresh IVF cycles due to
the controlled ovarian hyperstimulation medications and the
altered hormonal stimulation of the uterine lining
• Pelkonen et al. demonstrated that for frozen embryo transfers there
was a lower incidence of preterm birth, low birth weight, small for
gestational age infants, and a reduced need for intensive neonatal
care
41. Bed rest and Sexual Intercourse
Controversial subjects
• Evidence for bed rest: No benefit cf
Immediate ambulation
Anything more than a short period of bed rest
is without proven benefit
Sexual intercourse:
No need to avoid. No difference in outcome
Individualizing recommendations for patients’
preferences and anxiety is better
42. Adjuvant compounds to impact the uterus
• Tocolytics, prostaglandin synthetase inhibitors, and the use of
vaginal P as a uterine relaxant
Oral adminisration of piroxican 1 to 2 hours before ET significantly improved
pregnancy and implantation rates
• Impact of low-dose glucocorticoids before ET : indicate no
beneficial effect
• Use of Antibiotics, Aspirin ,sildenafil: Not recommended
Editor's Notes
Patient medical history - As OPU is performed under sedation or anaesthesia, a full blood count (FBC) and any additional test can be ordered, depending on local regulations regarding pre-operative management. There is no evidence suggesting value for FBC or any additional test before OPU with regard to preventing complications. - Patients should at least be asked about the use of medications - more specifically the use of blood thinning agents (aspirin and others) -, relevant previous surgeries, and any relevant disease or deficit of coagulation factors.
The pivot movement of the transvaginal transducer is easier when patient places her buttocks at the edge of the gynaecological couch and the operator is standing or sitting in between the patient’s abducted and supported legs. - Holding the transvaginal transducer in a correct way is advisable, as this will allow better vision of the proximity of the different tissues and organs on the monitor. Placing the transducer parallel to the hand of the operator results in better tactile perception as the transducer becomes an extension of the operator’s fingers. - The left side of the patient is often represented at the right part of the monitor. The probe is represented at the top or at the bottom of the monitor depending on the operator's preference. - Avoid contaminating the needle tip of the probe when introducing it in the vagina, by keeping the needle inside the needle guide until ready to pierce the vagina. - The ovary should be lined up to the most accessible position on the screen. - The transducershould be against the ovary (through the vaginal wall). Carefully insert the needle inside the follicle. - Ideally the needle should be inserted in the middle of the ovary to prevent the ovary from moving and needle to cause injury to adjacent organs. - The echogenic tip of the needle should be identified during all manoeuvres. The needle guide seen on the monitor can facilitate safer insertion as it projects where the needle tip will progress. - It is advised to keep the needle in the centre of the follicle during aspiration and observe the follicle walls to collapse around the tip. - The needle tip markers must be observed at all times as it is manoeuvred within the ovaries and into each follicle; the needle tip should never be advanced if not visible. - Aspirate the follicular fluid containing the oocyte/cumulus complex by application of suction. - The walls of the follicle collapse as the fluid is aspirated; before moving the needle to the next follicle, the operator should ensure that all the follicular fluid is withdrawn. - The needle can be advanced into an adjacent follicle or withdrawn to the edge of the ovary; realignment is needed to advance into another follicle. Minimize as far as possible repetitive puncture through the vaginal wall. - Avoid lateral movements of the needle to reduce the risk of vascular damage. - Do not move the transducer with the needle in the advanced position. - Puncture all follicles, especially if there is a high risk of ovarian hyperstimulation syndrome (OHSS). - Flush the needle between the two ovaries to avoid any potential blockage caused by blood clots.
Documentation : clear ,readable, OPU description with images and results (fx. how many oocytes obtained, difficulties during the procedure, information for future audit or research, information about the equipment
Forms should be available for admission and discharge, and for reporting on the procedure.
analyse key clinical performance indicators and it should be undertaken at least once per year in the IVF centre.
The entire OPU procedure should be audited at least once a year. This can be done by external auditors, quality managers or members of the same team observing each other performing
Management of hydrosalpinx : removal or clipping before OPU (Song et al., 2017). When a hydrosalpinx is only discovered during OPU, the first option should be oocyte or embryo cryopreservation. The benefit of aspiration on the day of OPU needs further study (Fouda et al., 2015, Hammadieh et al., 2008, Zhou et al., 2016).
Patients with potential infectious risk (HIV, hepatitis) should be managed in an isolated circuit or in specialized centres to avoid cross-contamination.
- In women with endometriosis, OPU can be challenging and it may affect the individual operator’s or centre’s performance rate (Kasapoglu et al., 2018). Endometriomas should not be aspirated. During OPU, the puncture of endometriomas should be avoided to prevent contamination of the follicular aspirate and reduce the risk of intra-abdominal infection. However, piercing the endometrioma is often the only way to avoid losing an important number of oocytes
. Dermoid cysts should not be punctured during OPU, since this could increase the risk of PID and peritonitis. In patients with an endometrioma or teratoma, the risk of PID is increased, even if they have not been punctured (Benaglia et al., 2008, Kasapoglu et al., 2018, Moini et al., 2005, Villette et al., 2016). These patients should be counselled preoperatively and consent obtained appropriately. –
If an endometrioma or a hemorrhagic follicle is inadvertently punctured, the needle should be immediately withdrawn and flushed with media, and the collecting tube should be changed.
- In patients with borderline ovarian tumours, it is unclear whether ART procedures are associated with an increased risk of recurrence (Denschlag et al., 2010). - Increased risk for bleeding has been suggested in lean women, and in women with polycystic ovary syndrome (PCOS) (L
Embryos can also move back into the cervix owing to capillary action whereby the fluid injected actually trailed the catheter as it is removed. To address this issue, Madani et al. (26) injected an additional amount of air after the embryo fluid column was injected. This extra air injection resulted in a significant improvement in implantation and pregnancy rates. It should be noted, however, that the presence of air bubbles does not completely alleviate this concern
Indeed, the percentage of embryos that were shrunken and/or collapsed increased in the rapid injection group. In addition, rates of apoptosis in the embryos of the rapid injection group were increased. Thus embryo trauma may be related to the rapidity of injection, and care should be taken to inject the fluid as slowly as possible. Additionally, in vitro modeling suggests that rapid injection may lead to embryo placement issues and possibly promote ectopic pregnancies